U.S. Hemophilia Treatment Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market Leaders

  • Takeda Pharmaceutical Unternehmen Limited
  • Sanofi Octapharma AG
  • Schwedisch Orphan Biovitrum AB
  • Baxter International Inc.
  • Biogen Inc.
*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

  • Takeda Pharmaceutical Unternehmen Limited
  • Sanofi Octapharma AG
  • Schwedisch Orphan Biovitrum AB
  • Baxter International Inc.
  • Biogen Inc.
  • Bayer AG
  • CSL Behring
  • Fähren B.V.
  • Pfizer, Inc.
  • Kedr.
  • Novo Nordisk
  • Grifols S.A.
  • Sangamo Therapeutics, Inc.
  • Funktherapie, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now